Search research articles
Contact Us
Filters
Showing results (81-90 of 191) with videos related to
Page
of 20
Sort By:
The Journal of Pathology
|
February 5, 2000
Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
P Thomas, R Khokha, F A Shepherd, et al.
Cancer Treatment Reports
|
February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma
R Feld, W K Evans, F A Shepherd, et al.
Investigational New Drugs
|
September 18, 1998
A phase II study of temozolomide in advanced untreated pancreatic cancer
M J Moore, R Feld, D Hedley, et al.
Current Oncology (Toronto, Ont.)
|
June 20, 2015
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
P M Ellis, N Coakley, R Feld, et al.
The American Journal of Medicine
|
July 1, 1987
Hepatic candidiasis: an increasing problem in immunocompromised patients
E Haron, R Feld, P Tuffnell, et al.
Gynecologic Oncology
|
May 1, 1992
Preoperative radiation therapy in clinical stage II endometrial carcinoma
S A Reisinger, E B Staros, R Feld, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 1996
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
F A Shepherd, R Burkes, Y Cormier, et al.
Cancer
|
October 15, 1988
Risk factors for varicella zoster disseminated infection among adult cancer patients with localized zoster
J J Rusthoven, P Ahlgren, T Elhakim, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 1, 1990
Experience with Ommaya reservoir in 120 consecutive patients with meningeal malignancy
R G Perrin, M Lishner, A Guha, et al.
Chest
|
April 1, 1993
The restaging of responding patients with limited small cell lung cancer. Is it really useful?
R Feld, J Pater, P J Goodwin, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 191) with videos related to
Sort By:
Page
of 20
The Journal of Pathology
|
February 5, 2000
Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
P Thomas, R Khokha, F A Shepherd, et al.
Cancer Treatment Reports
|
February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma
R Feld, W K Evans, F A Shepherd, et al.
Investigational New Drugs
|
September 18, 1998
A phase II study of temozolomide in advanced untreated pancreatic cancer
M J Moore, R Feld, D Hedley, et al.
Current Oncology (Toronto, Ont.)
|
June 20, 2015
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
P M Ellis, N Coakley, R Feld, et al.
The American Journal of Medicine
|
July 1, 1987
Hepatic candidiasis: an increasing problem in immunocompromised patients
E Haron, R Feld, P Tuffnell, et al.
Gynecologic Oncology
|
May 1, 1992
Preoperative radiation therapy in clinical stage II endometrial carcinoma
S A Reisinger, E B Staros, R Feld, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 1, 1996
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
F A Shepherd, R Burkes, Y Cormier, et al.
Cancer
|
October 15, 1988
Risk factors for varicella zoster disseminated infection among adult cancer patients with localized zoster
J J Rusthoven, P Ahlgren, T Elhakim, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 1, 1990
Experience with Ommaya reservoir in 120 consecutive patients with meningeal malignancy
R G Perrin, M Lishner, A Guha, et al.
Chest
|
April 1, 1993
The restaging of responding patients with limited small cell lung cancer. Is it really useful?
R Feld, J Pater, P J Goodwin, et al.
Page
of 20